famotidine has been researched along with antipyrine in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (43.75) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (25.00) | 29.6817 |
2010's | 5 (31.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kitchingman, GA; Langman, MJ; Somerville, KW | 1 |
Akamatsu, K; Hirabayashi, Y; Kanaoka, M; Masumoto, S; Nakanishi, K; Nishinobu, M; Ohta, Y; Okada, S; Sakaue, H; Sasaki, T | 1 |
Dicke, JM; Henderson, GI; Johnson, RF; Kuehl, TJ; Schenker, S | 1 |
Kuroiwa, Y; Misawa, S; Nakamura, K; Tanaka, E | 1 |
Del Prete, U; Jèzèquel, AM; Orlandi, F; Piersimoni, F | 1 |
Dammann, HG; DeVries, JX; Koroknay, B; Müller, P; Simon, B; Staiger, C; Weber, E | 1 |
Dammann, HG; Devries, JX; Korodnay, B; Müller, P; Simon, B; Staiger, C; Weber, E | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Avdeef, A; Tam, KY | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
1 trial(s) available for famotidine and antipyrine
Article | Year |
---|---|
[Comparative study of the effect of famotidine and cimetidine on antipyrine pharmacokinetics in the human].
Topics: Adult; Antipyrine; Cimetidine; Famotidine; Female; Histamine H1 Antagonists; Humans; Kinetics; Male; Thiazoles | 1984 |
15 other study(ies) available for famotidine and antipyrine
Article | Year |
---|---|
Effect of famotidine on oxidative drug metabolism.
Topics: Adult; Aminopyrine; Antipyrine; Breath Tests; Famotidine; Half-Life; Histamine H2 Antagonists; Humans; Kinetics; Male; Oxidation-Reduction; Pharmaceutical Preparations; Thiazoles | 1986 |
Effects of prolonged oral cimetidine, ranitidine, and famotidine therapy on antipyrine elimination.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antipyrine; Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Humans; Liver; Male; Metabolic Clearance Rate; Middle Aged; Ranitidine; Thiazoles | 1987 |
A comparative evaluation of the transport of H2-receptor antagonists by the human and baboon placenta.
Topics: Adolescent; Adult; Animals; Antipyrine; Biological Transport; Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Humans; In Vitro Techniques; Maternal-Fetal Exchange; Nizatidine; Papio; Perfusion; Placenta; Pregnancy; Ranitidine; Thiazoles | 1988 |
The effect of H2-receptor antagonists on antipyrine and pentobarbital metabolism in male and female rats.
Topics: Animals; Antipyrine; Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Male; Microsomes, Liver; Mixed Function Oxygenases; Pentobarbital; Ranitidine; Rats; Rats, Inbred Strains; Sex Factors; Thiazoles | 1988 |
The effect of famotidine, a new H2 receptor antagonist, on antipyrine clearance in healthy volunteers.
Topics: Adult; Antipyrine; Famotidine; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Receptors, Histamine H2; Saliva; Thiazoles | 1987 |
Comparative effects of famotidine and cimetidine on antipyrine kinetics in healthy volunteers.
Topics: Adult; Antipyrine; Cimetidine; Famotidine; Female; Humans; Kinetics; Male; Thiazoles | 1984 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |